Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | St. Jude Children'S Research Hospital |
| Country | United States |
| Start Date | Sep 01, 2024 |
| End Date | Aug 31, 2025 |
| Duration | 364 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 11142247 |
PROJECT ABSTRACT Childhood cancer survivors are a high-priority, underserved population for HPV vaccination. They are less likely to be vaccinated when compared to the general population and are more likely to develop second cancers caused by HPV as adults. St. Jude Comprehensive Cancer Center (SJCCC) is uniquely positioned to
address observed disparities in HPV vaccination coverage among childhood cancer survivors by leveraging our unique reach across our catchment area and building on award-winning, state-of-the-art communication systems with those treated at SJCCC and their families. The purpose of this proposal is, therefore, to further
develop, optimize, and evaluate the Survivor Proud campaign to promote HPV vaccination to childhood cancer survivors (Track 1: 9-30-years). We will focus specifically on continuous quality improvement of the campaign through ongoing evaluation activities and successfully sustaining elements of the campaign that are most
effective. We also will focus on important wrap-around activities in support of the communication campaign, including peer-to-peer efforts for patient families and clinician education and training. We will leverage established infrastructure and collaborations to achieve the following specific aims: 1) Optimize and expand the
innovative, culturally targeted, multi-channel Survivor Proud communication campaign to enhance health literacy related to HPV vaccination and to improve HPV vaccination coverage among CCS; and 2) Evaluate the impact of the campaign to understand its impact on awareness, knowledge, intentions to get HPV vaccination,
and actual HPV vaccination, when data are available. Our approach will be highly iterative and include engagement of key offices within St. Jude and most importantly, through our continued regular interaction with patient families and adult childhood cancer survivors. The Survivor Proud campaign focuses on web-based
resources and communities, social media platforms, mobile application (app), traditional print formats, electronic medical record (EMR) prompted patient education prescriptions, direct e-communication, peer-to- peer, patient family experiences, and clinician training and education. The Survivor Proud HPV vaccination
campaign has first been developed in English (and will be developed in Spanish) will be evaluated across these communication channels. A focus of the campaign is to build confidence in HPV vaccination leveraging the trusted relationship patient families have with St. Jude. Project activities are documented and monitored
through a comprehensive process evaluation. Preliminary impact of our efforts will also be measured using qualitative, quantitative, and analytical data, including assessment of aggregated HPV vaccination rates before and after campaign implementation. Our efforts will be aligned with existing St. Jude resources from the
beginning to optimize sustainability. We will openly share our findings with other cancer centers and organizations serving CCS and continue to refine and test our approaches to ensure we are achieving impact through increased HPV vaccination coverage among childhood cancer survivors.
St. Jude Children'S Research Hospital
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant